TY  - JOUR
PY  - 2005//
TI  - Pharmacotherapy of suicidal behavior in bipolar disorder
JO  - Archives of suicide research
A1  - Oquendo, Maria A.
A1  - Chaudhury, Sadia R.
A1  - Mann, J. John
SP  - 237
EP  - 250
VL  - 9
IS  - 3
N2  - Patients with Bipolar Disorder (BD) are at particularly high risk for both attempted and completed suicides. The period of highest risk for completed suicide is during the 2 years following discharge from a hospitalization. To date, pharmacological studies of suicidal behavior in BD have been quite limited. While strong evidence has been found regarding the anti-suicidal effects of lithium, evidence for such properties in other commonly prescribed medications for BD, including anticonvulsants, SSRIs and anti-psychotics, has been largely unexplored. Considering the high risk of suicidal acts in patients with BD, further research on the pharmacotherapy of suicidal behavior is crucial.<p />  <p>Language: en</p>
LA  - en
SN  - 1381-1118
UR  - http://dx.doi.org/10.1080/13811110590929424
ID  - ref1
ER  -